Board meeting scheduled for May 27, 2026 to approve audited standalone financial results for Q4 and FY ending March 31, 2026.
Agenda includes approval of standalone balance sheet and cash flow statements for half-year ended March 31, 2026.
Trading window closure from April 1, 2026 until 48 hours after results declaration was previously intimated.